STOCKHOLM, Sweden, Sept. 12, 2003 (PRIMEZONE) -- Elekta AB (Other OTC:EKTAF):
-- The Board proposes a redemption of every seventeenth share
for SEK 165 per share
-- Through the redemption, approximately SEK 319.8 million is
proposed to be transferred to the shareholders
The Board of Directors of Elekta AB (publ) has today established the conditions for its proposal regarding redemption of shares to the Annual General Meeting to be held on September 22, 2003. According to the proposal, every seventeenth share may be redeemed for SEK 165 in cash. For every share held in Elekta, one redemption right will be received. Seventeen redemption rights entitle the holder to redeem one share. Assuming full acceptance of the redemption offer, approximately 1.9 million shares will be redeemed and approximately SEK 319.8 million transferred to the shareholders in Elekta.
Time table (assuming the Annual General Meeting's approval):
Last day of trading shares in Elekta including redemption rights: September 30, 2003 First day of trading shares in Elekta excluding redemption rights: October 1, 2003 Record date for receiving redemption rights: October 3, 2003 Information brochure and application form distributed: October 8, 2003 Application period: October 13 - November 11, 2003 Trading in redemption rights on Stockholmsborsen October 13 - November 6, 2003
A sale of up to 2,000 redemption rights free of commission will be provided through D. Carnegie AB ("Carnegie") during October 13 - October 31, 2003 following a specific application procedure. Before payment of the redemption proceeds can be made, the court's permission must be obtained and the permission registered with the Swedish Patent and Registration Office, which is estimated to take place at the end of March 2004.
Carnegie is the financial advisor to Elekta AB in connection with the redemption offer.
For further information, please contact: Shareholders who whish to receive further information regarding the application procedure etc. in the redemption offer, may call Carnegie's transaction support at +46 8 588 694 81.
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.
For additional information about Elekta, visit www.elekta.com
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2003/09/12/20030912BIT00170/wkr0001.doc
http://www.waymaker.net/bitonline/2003/09/12/20030912BIT00170/wkr0002.pdf